Medicare Enrolled

Dr. Michael Misuraca, DO

Nephrology · Livonia, MI
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
18302 MIDDLEBELT RD, Livonia, MI 48152
2484781500
In practice since 2007 (19 years)
NPI: 1982826699 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Misuraca from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Misuraca? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Misuraca

Dr. Michael Misuraca is a nephrology specialist in Livonia, MI, with 19 years of NPI registration. Based on federal Medicare data, Dr. Misuraca performed 2,239 Medicare services across 1,030 unique beneficiaries.

Between the years covered by Open Payments, Dr. Misuraca received a total of $10,318 from 33 pharmaceutical and/or device companies across 377 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nephrology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Misuraca is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 19% volume in MI $10,318 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,239
Medicare services
Top 19% in MI for nephrology
1,030
Unique beneficiaries
$106
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~118 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
524 $64 $128
Dialysis services for patients 20 or older
Dialysis treatment provided to patients aged 20 years or older, involving four or more physician visits per month.
290 $271 $546
Hemodialysis, single evaluation
A dialysis procedure to filter waste from the blood, performed with a physician's evaluation.
224 $58 $144
Complex chronic care management, first 60 minutes
This service involves clinical staff time directed by a healthcare professional to manage two or more chronic conditions over a calendar month. It covers the first 60 minutes of this coordinated care effort.
207 $105 $140
Additional chronic care management time, 60 minutes
This service covers an additional 60 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions, billed per calendar month.
178 $56 $100
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
163 $141 $292
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
138 $2 $10
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
127 $97 $185
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
98 $61 $189
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
87 $52 $138
Dialysis services for adults, 2-3 visits per month
This code covers dialysis services for patients aged 20 or older who have 2 to 3 physician visits per month.
70 $233 $464
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
67 $106 $222
Home dialysis services per month
Monthly dialysis treatment provided in the patient's home for individuals aged 20 or older.
33 $235 $464
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
20 $116 $261
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
13 $84 $180
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$10,318
Total received (2018-2024)
Avg $1,474/year across 7 years
Top 8% in MI for nephrology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
33
Companies
377
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,212 (99.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$106 (1.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,742
2023
$1,722
2022
$1,523
2021
$1,012
2020
$1,093
2019
$1,803
2018
$1,423

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$316
Bayer Healthcare Pharmaceuticals Inc.
$259
AstraZeneca Pharmaceuticals LP
$174
Otsuka America Pharmaceutical, Inc.
$156
Boehringer Ingelheim Pharmaceuticals, Inc.
$146
Travere Therapeutics, Inc.
$144
Aurinia Pharma U.S., Inc.
$89
GENZYME CORPORATION
$79
Novartis Pharmaceuticals Corporation
$68
Vifor Pharma, Inc.
$63
Ardelyx, Inc.
$48
AKEBIA THERAPEUTICS INC
$47
CALLIDITAS THERAPEUTICS US INC.
$41
OPKO Pharmaceuticals, LLC
$38
Alexion Pharmaceuticals, Inc.
$26
Mallinckrodt Hospital Products Inc.
$26
Fresenius USA Marketing, Inc.
$21
Top 3 companies account for 43.0% of 2024 payments
All-time payments by company (2018-2024) ›
Relypsa, Inc.
$951
Otsuka America Pharmaceutical, Inc.
$842
AstraZeneca Pharmaceuticals LP
$842
Travere Therapeutics, Inc.
$666
Amgen Inc.
$585
Vifor Pharma, Inc.
$565
Mallinckrodt Hospital Products Inc.
$501
Aurinia Pharma U.S., Inc.
$472
Alexion Pharmaceuticals, Inc.
$451
GENZYME CORPORATION
$412
Fresenius USA Marketing, Inc.
$399
Mallinckrodt LLC
$378
OPKO Pharmaceuticals, LLC
$353
AKEBIA THERAPEUTICS INC
$329
Calliditas Therapeutics US Inc.
$308
Mallinckrodt Enterprises LLC
$302
Bayer Healthcare Pharmaceuticals Inc.
$301
GlaxoSmithKline, LLC.
$282
Bayer HealthCare Pharmaceuticals Inc.
$197
Horizon Therapeutics plc
$166
Boehringer Ingelheim Pharmaceuticals, Inc.
$146
Genentech USA, Inc.
$141
Keryx Biopharmaceuticals, Inc.
$131
Lundbeck LLC
$130
Novo Nordisk Inc
$120
Novartis Pharmaceuticals Corporation
$110
CALLIDITAS THERAPEUTICS US INC.
$73
Daiichi Sankyo Inc.
$53
Ardelyx, Inc.
$48
Alnylam Pharmaceuticals Inc.
$20
ANI Pharmaceuticals, Inc.
$17
NxStage Medical, Inc.
$12
Ultragenyx Pharmaceutical Inc.
$12
Top 3 companies account for 25.5% of all-time payments
Associated products mentioned in payments ›
2008K @ Home · ACTHAR · AURYXIA · Auryxia · BENLYSTA · Crysvita · ENTRESTO · FABRAZYME · FABRY-DISEASE · FARXIGA · IBSRELA · INJECTAFER · JARDIANCE · JESDUVROQ · JYNARQUE · KRYSTEXXA · Kerendia · LOKELMA · LUPKYNIS · NORTHERA · OXLUMO · PUREFLOW SL · PURIFIED CORTROPHIN GEL · Parsabiv · RAYALDEE · Rayaldee · Rituxan · SAMSCA · SOLIRIS · TARPEYO · TAVNEOS · Thiola · ULTOMIRIS · Ultomiris · Velphoro · Veltassa
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for nephrology in MI.

Looking for a nephrology specialist in Livonia?
Compare nephrologists in the Livonia area by procedure volume, costs, and industry payment transparency.
Browse nephrologists nearby

Geographic Context

Nephrologists within 10 mi
160
Per 100K population
9.0
County median income
$59,521
Nearest hospital
ST JOE MERCY HOSPITAL SYSTEM LIVONIA
1.9 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Misuraca is a clinical cardiology specialist, with above-average Medicare volume (top 19% in MI), with low-engagement industry engagement in the top 8% of MI peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Misuraca experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Misuraca performed 524 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Misuraca receive payments from pharmaceutical companies?
Yes. Dr. Misuraca received a total of $10,318 from 33 companies across 377 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Misuraca's costs compare to other nephrologists in Livonia?
Dr. Misuraca's average Medicare payment per service is $106. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Misuraca) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →